Skip to main content
Back to Bills
OntarioDid not become law (session ended)39th Parliament, 2nd Session

Bill 165 explained in plain English

Sickle Cell and Thalassemia Care Ontario Act, 2011

Ontario legislature bill summary, status, timeline, sponsor, votes, and official sources.

At a glance

Jurisdiction
Ontario Legislature
Legislature / Parliament
Legislative Assembly of Ontario
Session
39th Parliament, 2nd Session
Bill number
Bill 165
Full title
Sickle Cell and Thalassemia Care Ontario Act, 2011
Current status
Did not become law (session ended)
Latest event
Carried
Last updated
Mar 10, 2011
Sponsor

Official Legislative Assembly of Ontario snapshot for 39th Parliament, 2nd Session. Representative vote breakdowns appear when the Assembly publishes an Ayes and Nays page for the bill.

Chamber
Legislative Assembly of Ontario
Current Stage
Carried
Latest Activity
Mar 10, 2011
Sponsor
Plain-language explanation
In plain English (our explanation)

Our plain-language take, written for civic education.

Source: By PoliticalData.ca

AI-assisted, reviewed before publishing
Short Version

Bill 165, the Sickle Cell and Thalassemia Care Ontario Act, 2011, creates a corporation to improve care for these disorders and designates June 19th as an awareness day.

What It Means

This bill establishes Sickle Cell and Thalassemia Care Ontario, a non-profit corporation, to improve healthcare coordination and quality for individuals with sickle cell or thalassemia disorders. It also proclaims June 19th each year as Sickle Cell and Thalassemia Awareness Day.

What This Bill Does
  • Establishes Sickle Cell and Thalassemia Care Ontario as a corporation without share capital.
  • Outlines the objects of the Corporation, including improving healthcare coordination, promoting awareness, assisting patients and caregivers, advocating for patients, encouraging genetic testing, facilitating access to genetic counseling, monitoring disorder prevalence, and collaborating with other governments.
  • Specifies the composition of the Corporation's board of directors, appointed by the Lieutenant Governor in Council.
  • Requires the Corporation to appoint auditors and provide them with an annual report.
  • Grants the Minister the power to audit the Corporation's affairs.
  • Proclaims June 19th of each year as Sickle Cell and Thalassemia Awareness Day.
  • States that the Act comes into force on the day it receives Royal Assent.
  • Provides the short title of the Act.
Who Is Affected
  • Individuals with sickle cell disorders
  • Individuals with thalassemia disorders
  • Caregivers of individuals with sickle cell or thalassemia disorders
  • Health professionals
  • Hospitals
  • Research institutions
  • Advocacy groups
  • The public
  • The Government of Canada
  • Provincial and territorial governments in Canada
  • Members of the Legislative Assembly of Ontario
  • The Minister of Health and Long-Term Care (or equivalent)
  • The Lieutenant Governor in Council
Rights, Duties, Or Obligations
  • The Corporation has a duty to improve healthcare coordination and quality for individuals with sickle cell or thalassemia disorders.
  • The Corporation has a duty to promote public awareness and education about these disorders.
  • The Corporation must assist patients and caregivers in accessing healthcare and social support resources.
  • The Corporation must advocate on behalf of affected individuals.
  • The Corporation is encouraged to promote genetic testing and counseling.
  • The Corporation must monitor the prevalence of these disorders and assess healthcare service sufficiency.
  • The Corporation must provide an annual report to the Minister.
  • The Minister must lay the annual report before the Legislative Assembly.
Important Dates
  • The Act comes into force on the day it receives Royal Assent.
  • June 19th is proclaimed as Sickle Cell and Thalassemia Awareness Day each year.
Financial Or Tax Impacts
  • The Corporation must appoint auditors licensed under the Public Accounting Act, 2004, which may incur costs for the Corporation.
Uncertainties Or Limits
  • The bill does not specify the exact composition or appointment process for the board of directors beyond a minimum and maximum number of members and appointment by the Lieutenant Governor in Council.
  • The bill does not detail the specific funding mechanisms or budget for Sickle Cell and Thalassemia Care Ontario.
  • The bill does not specify how the Corporation will be implemented or its operational details.
  • The bill does not detail the penalties for non-compliance, if any, as it focuses on establishing a corporation and an awareness day.
Laws Or Regulations Affected
Sickle Cell and Thalassemia Care Ontario Act, 2011
enactment

This Act creates a new non-profit corporation and establishes an annual awareness day.

Executive Council Act
amendment

This Act may assign or transfer responsibility for the administration of the Sickle Cell and Thalassemia Care Ontario Act, 2011 to a member of the Executive Council.

Source: Section 1

Public Accounting Act, 2004
reference

The Corporation must appoint auditors licensed under this Act.

Source: Section 5 (1)

Generated using AI from official bill text. Not legal advice. It is written by PoliticalData.ca for civic education, automatically checked and spot-reviewed before publishing.

Official text

Process Snapshot

Step 1
First reading
Mar 10, 2011
Step 2
Second reading
Not reached yet
Step 3
Committee review
Not reached yet
Step 4
Third reading
Not reached yet
Step 5
Royal assent
Not reached yet

Vote Summary

No published recorded division

This bill is still active. We only show vote counts after the legislature publishes a recorded division.

Sponsor
Mike Colle
Sponsor party or district not listed
Jurisdiction
Ontario Legislature

No published representative vote breakdown

This bill is still moving through the process. When a recorded division is published, representative positions can be listed here.

Official sources

Status, sponsor, votes, and timeline on this page are drawn from these official legislative sources and public records. Each summary above is attributed to its own source.

How this data is sourced